Capsazepine, TRPV1 antagonist
Capsazepine, TRPV1 antagonist
Be the first to review this product! Submit a review
|
(7 Publications)
MW 376.9 Da, Purity >98%. TRPV1 vanilloid receptor antagonist (IC50 = 562 nM). Analgesic in vivo.
別名を表示する
Capsaicin receptor, DKFZp434K0220, OTRPC1, Osm-9-like TRP channel 1, TRPV1_HUMAN, Transient receptor potential cation channel subfamily V member 1, VR 1, Vanilloid receptor 1, Vanilloid receptor subtype 1
- Chemical Structure
Lab
Chemical Structure - Capsazepine, TRPV1 antagonist (AB120025)
2D chemical structure image of ab120025, Capsazepine, TRPV1 antagonist
出荷温度及び保存条件
出荷温度
短期保存温度
長期保存温度
保管に関する情報
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of TRPV1 extends beyond sensory perception. It is involved in detecting and regulating body temperature and is activated by heat acidic conditions and certain lipid metabolites. The receptor operates as part of a homotetrameric complex contributing to neural signaling. It is activated by chemical ligands such as capsaicin the compound responsible for the spicy sensation in chili peppers influencing pain and inflammation pathways.
Pathways
TRPV1 plays essential roles in pain and nociception pathways. It intersects with the inflammatory pathway where its activity is modulated by protein kinase C (PKC) and phospholipase C (PLC). These pathways involve calcium signaling and relate to proteins such as PKA and calcineurin which modulate TRPV1 activity through phosphorylation and dephosphorylation affecting the body's response to noxious stimuli.
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
European journal of pharmacology 718:154-9 PubMed24041928
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 31:7089-101 PubMed21562271
2011
Applications
Unspecified application
Species
Unspecified reactive species
Neuropharmacology 60:674-82 PubMed21130785
2010
Applications
Unspecified application
Species
Unspecified reactive species
Pain 152:106-113 PubMed20971560
2010
Applications
Unspecified application
Species
Unspecified reactive species
Neurogastroenterology and motility : the official 20:546-56 PubMed18194153
2008
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Gastrointestinal and liver physiology 294:G245-53 PubMed17991707
2007
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 148:489-500 PubMed17683869
2007
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com